Allergic rhinitis is a serious medical and social problem associated with the continuously increasing morbidity level and imposing a high economic burden on the healthcare delivery system for the management of this condition. In accordance with the concept of "personalized medicine", the prescription of intranasal or oral antihistaminic agents, intranasal glucocorticosteroids and oral antagonists of antileukotrienic medicines as well as decongestants and therapeutic preparations of other classes for the treatment of allergic rhinitis should be well substantiated and based on an individual approach to a patient in every particular case.